Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up

Affiliations

• ¹ Department of Neurology, University Hospital of Heidelberg, Heidelberg, Germany.
• ² European Oncology Nursing Society, Brussels, Belgium.
• ³ Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.
• ⁴ Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
• ⁵ Department of Oncology, University Hospital of North Norway, Tromsoe, Norway; Institute of Medicine, UIT - The Arctic University, Tromsoe, Norway.
• ⁶ University of Halle, Nursing Research Unit, Halle, Germany.
• ⁷ University of Lille, Inserm, U-1192, Lille, France; CHU Lille, Neuro-oncology, General and Stereotaxic Neurosurgery Service, Lille, France; Breast Cancer Department, Oscar Lambret Center, Lille cedex, France; Department of Neurology and Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
• ⁸ Clinical Division of Oncology, Comprehensive Cancer Center CNS Tumours Unit, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
• ⁹ Gustave Roussy Cancer Campus, Interdisciplinary Cancer Course Department, Villejuif, France.
• ¹⁰ Department of Neurology, Leiden University Medical Center and Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
• ¹¹ Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.